Literature DB >> 8088771

Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey.

S Kobayashi1, Y Nakanuma, O Matsui.   

Abstract

The peribiliary vascular plexus (PVP) plays an important role in the pathophysiology of the biliary tree. We histologically examined vascular endothelial cells of the intrahepatic PVP in various hepatobiliary diseases by immunohistochemistry and lectin histochemistry with antibodies to factor VIII-related antigens (F-VIII-R-Ag) and Ulex europaeus agglutinin I (UEA-I). The PVP around the intrahepatic large bile ducts (LBDs) and septal bile ducts (SBDs) in normal livers consists of three layers: inner layer vessels immediately adjacent to the epithelium, intermediate layer vessels within the ductal wall, and outer layer vessels outside the ductal wall. In some bile ducts that show active inflammation in hepatolithiasis, primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and extrahepatic biliary obstruction (EBO), vessels in the intermediate layer and, to a lesser degree, in the inner layer, are increased in number. In sclerotic bile ducts of PSC, EBO, and hepatolithiasis, the number of inner and intermediate layer vessels are markedly and variably reduced, respectively. In liver cirrhosis or chronic advanced liver diseases, the vessels in all three layers, particularly those in the outer layer, are increased in number and dilated, probably reflecting intrahepatic microcirculatory disturbance. The PVP showed several types of numerical and luminal changes, each of which may be related to disease processes in the intrahepatic biliary tree as well as to intrahepatic microcirculatory disturbance.

Entities:  

Mesh:

Year:  1994        PMID: 8088771     DOI: 10.1016/0046-8177(94)90016-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  16 in total

Review 1.  Current status of hepatocellular carcinoma treatment in Japan: transarterial chemoembolization.

Authors:  Osamu Matsui
Journal:  Clin Drug Investig       Date:  2012-08-08       Impact factor: 2.859

2.  Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregates.

Authors:  Aftab Ala; David Brown; Korsa Khan; Richard Standish; Joseph A Odin; M Isabel Fiel; Thomas D Schiano; Kenneth J Hillan; Syed A Rahman; Humphrey J F Hodgson; Amar P Dhillon
Journal:  Dig Dis Sci       Date:  2013-07-10       Impact factor: 3.199

Review 3.  Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.

Authors:  Pedro Martins; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2019-07-30

Review 4.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

5.  Portal venous arterialization resulting in increased portal inflow and portal vein wall thickness in rats.

Authors:  Wen-Gang Li; Yong-Liang Chen; Jing-Xi Chen; Lei Qu; Bin-Dang Xue; Zhi-Hai Peng; Zhi-Qiang Huang
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

6.  Hepatic artery and portal vein remodeling in rat liver: vascular response to selective cholangiocyte proliferation.

Authors:  Tatyana V Masyuk; Erik L Ritman; Nicholas F LaRusso
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

7.  High Rate of Gastrointestinal Bleeding in Patients with Secondary Sclerosing Cholangitis in Critically Ill Patients (SC-CIP).

Authors:  Andreas Blesl; Martin Eibisberger; Michael Schörghuber; Christoph Klivinyi; Vanessa Stadlbauer
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

8.  Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19.

Authors:  Simon Bütikofer; Daniela Lenggenhager; Pedro D Wendel Garcia; Ewerton M Maggio; Martina Haberecker; Cäcilia S Reiner; Gregor Brüllmann; Philipp K Buehler; Christoph Gubler; Beat Müllhaupt; Christoph Jüngst; Bernhard Morell
Journal:  Liver Int       Date:  2021-07-04       Impact factor: 8.754

9.  Tutorial review for understanding of cholangiopathy.

Authors:  Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2011-08-17

Review 10.  Update on Sclerosing Cholangitis in Critically Ill Patients.

Authors:  Gabriele I Kirchner; Petra Rümmele
Journal:  Viszeralmedizin       Date:  2015-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.